Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • puggie
    Member
    • Nov 2011
    • 52

    #1

    Coverage of Rare Events (General Considereations)

    Dear Forum Members,

    First my apologies if this is not the correct forum thread for my question.

    Im working on RNA-seq PE.

    Lets say one was looking at events that are rare (low coverage), what is the general consensus (considerations) regarding the validity of such data.

    I have looked through litterature and this is not always taken into consideration I believe.

    E.g. if < 5 read pairs support an observation.

    Having >300.000.000 from a single flow lane, then just by chance one could expect a read pair to be false e.g. wrong mates are connected or something else strange thing happening. I guess this comes down to the accuracy of NGS, validation by conventional techniques (if possible), sequence identity to the specific region etc.

    However, what is your opinion in this respect?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...